Edition:
United States

Laboratory Corporation of America Holdings (LH.N)

LH.N on New York Stock Exchange

150.36USD
17 Nov 2017
Change (% chg)

$-0.66 (-0.44%)
Prev Close
$151.02
Open
$150.44
Day's High
$151.15
Day's Low
$149.93
Volume
130,530
Avg. Vol
164,347
52-wk High
$164.20
52-wk Low
$123.37

Select another date:

BRIEF-Labcorp - Co,‍ Capital Health announced that they have entered into a laboratory partnership​

* Labcorp - Co,‍ Capital Health announced that they have entered into a laboratory partnership​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Diagnostics power LabCorp's beat-and-raise quarter

Laboratory Corp of America Holdings' profit topped analysts' estimates and the company raised its full-year revenue growth forecast on Wednesday, expecting growth from its diagnostics business.

UPDATE 2-Diagnostics power LabCorp's beat-and-raise quarter

Oct 25 Laboratory Corp of America Holdings' profit topped analysts' estimates and the company raised its full-year revenue growth forecast on Wednesday, expecting growth from its diagnostics business.

LabCorp posts marginal rise in quarterly profit

Oct 25 Laboratory Corp of America Holdings reported a marginal rise in quarterly profit, helped by higher demand for its diagnostic services, even as costs rose.

BRIEF-Interpace Diagnostics announces renewal and extension of LabCorp national agreement

* Interpace Diagnostics announces renewal and extension of LabCorp national agreement

BRIEF-Chromadex sells its analytical testing business to LabCorp

* Chromadex sells its analytical testing business to LabCorp, to accelerate the expansion of Nicotinamide Riboside and its other patented ingredient technologies

BRIEF-LabCorp announces proposed sale of senior notes

Aug 15 Laboratory Corporation Of America Holdings:

Select another date: